Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061588

SVP & Chief Scientific Officer returned 4,782 shares (to the company)

  • SVP & Chief Scientific Officer acquired 17,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Doberstein Stephen K · SVP & Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-15 Grant or award : show line 1 in the form +17,500 48,602 D
2017-11-16 Returned to the company : show line 2 in the form −4,782 $44.23 $211,508 43,820 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-11-15 Grant or award : show line 3 in the form Stock Option +43,750 43,750 D
Loading xslF345X03/doc4.xml…